Vertex Pharmaceuticals (VRTX) Acquisitions (2009 - 2019)
Vertex Pharmaceuticals (VRTX) recorded quarterly Acquisitions of $908.4 million in Q4 2019, up 939.07% quarter-over-quarter from $87.4 million in Q1 2009.
Vertex Pharmaceuticals (VRTX) Acquisitions (2009 - 2019) Analysis & Trends
Vertex Pharmaceuticals' Acquisitions history runs 2 years deep, the most recent figure standing at $908.4 million for Q4 2019.
- In Q4 2019, Acquisitions changed N/A year-over-year to $908.4 million; the TTM figure through Dec 2022 stood at $908.4 million (changed 0.0% YoY), while the FY2022 annual figure was $295.9 million, changed N/A from the prior year.
- Acquisitions was $908.4 million for Q4 2019 at Vertex Pharmaceuticals, up from $87.4 million in the prior quarter.
- In the past five years, Acquisitions ranged from a high of $908.4 million in Q4 2019 to a low of $908.4 million in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 908.38 Mn |
| Mar 31, 2009 | 87.42 Mn |